AFP and carcinoma: Most prominently, the level of core fucosylation of N-glycan in alpha-fetoprotein (AFP) increases in hepatocellular carcinomas (HCC) and carcinoma metastatic to the liver, but not in benign liver diseases, such as acute viral hepatitis, chronic hepatitis, or liver cirrhosis2.